Beneficial influence of postmenopausal estrogen therapy on serum adhesion molecules is independent of the route and dose of administration

Neuroendocrinology Letters

Volumn 32, Issue 3, 2011, Pages 340-344

  Rajtar Ciosek, Agnieszka ^a   Huras, Hubert ^a   Krzysiek, Józef ^a   Reroń, Alfred ^a   Wilczak, Maciej ^b   Jach, Robert ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b Department of Medical Education UM ^*  (Poland)

Author keywords

Adhesion molecules; Combined estrogen progestin therapy; Menopause

Indexed keywords

CELL ADHESION MOLECULE; DYDROGESTERONE; ESTRADIOL; ESTRADIOL PLUS NORETHISTERONE ACETATE; ESTROGEN; FOLLITROPIN; INTERCELLULAR ADHESION MOLECULE 1; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE ACETATE; VASCULAR CELL ADHESION MOLECULE 1;

ADL DISABILITY; ADULT; ARTICLE; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; FOLLITROPIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; POLAND; POSTMENOPAUSE; PROTEIN BLOOD LEVEL;

EID: 80051971610     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Cho SH (2000) The vascular effects of progesterone/progestogens.The Menopause the Millennium. 47: 293.
2. Danesh J, Collins R, Peto R (1997) Chronic infections and coronary heart disease: is there a link? Lancet. 350: 430-436.
3. De Backer J, Mak R, De Bacquer D, Van Renterghem L, Verbraekel E, Kornitzer M, et al. (2002) Parameters of inflammation and infection in a community based case-control study of coronary heart disease. Atherosclerosis. 160: 457-463. (Pubitemid 34159341)
4. Dechend R, Maass M, Gieffers J, Dietz R, Scheidereit C, Leutz A, et al. (1999) Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosis. Circulation. 100: 1369-1373.
5. Goudev A, Georgiev DB, Koycheva N, Manasiev N, Kyurkchiev S (2002) Effects of low dose hormone replacement therapy on markers of inflammation in postmenopausal women. Maturitas. 43: 49-53. (Pubitemid 35254065)
6. Lamon-Fava S, Posfai B, Schaefer EJ (2003) Effect of hormonal replacement therapy on C-reactive protein and cell-adhesion molecules in postmenopausal women. Am J Cardiol. 91: 252-254.
7. Mueck AO, Genazzani AR, Samsioe G, Vukovic-Wysocki I, Seeger H (2007) Low-dose continuous combinations of hormone therapy and biochemical surrogate markers for vascular tone and inflammation: transdermal versus oral application. Menopause. 14: 978-984. (Pubitemid 350098656)
8. Ptak W, Ptak M (1999) Immunology. Cracow: Jagiellonian University Publishing.
9. Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J (1998) Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet. 351: 88-92. (Pubitemid 28026634)
10. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al, Writing Group for the Women's Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 288: 321-333. (Pubitemid 34761611)
11. Shifren JL, Rifai N, Desindes S, McIlwain M, Doros G, Mazer NA (2008) A comparison of the short-term effects of oral conjugated equine estrogens versus transdermal estradiol on C-reactive protein, other serum markers of inflammation, and other hepatic proteins in naturally menopausal women. J Clin Endocrinol Metab. 93: 1702-1710. (Pubitemid 351656508)